filmov
tv
Longitudinal Testing at Tempus
Показать описание
When cancer recurs after immunotherapy prior targeted therapies are often ineffective, and understanding the changes in the cancer's molecular makeup help adjust treatment approaches. Thus a second molecular assay is needed to gain valuable insights for advanced, recurred, cancers.
Made with Vidra
Made with Vidra
0:00:43
0:00:44
0:03:16
0:02:10
0:00:54
0:04:03
0:58:17
0:51:35
0:18:38
0:37:12
0:00:40
0:01:48
0:03:02
0:58:54
0:00:33
0:57:07
1:40:13
0:06:05
0:02:01
0:09:09
0:10:47
1:15:40
0:06:28
0:30:17